The Jumpstarting Brain Tumor Drug Development Coalition (JBTDDC) is offering a new consensus protocol for magnetic resonance imaging (MRI) in brain tumor clinical trials to help in the assessment of whether a new treatment is effective.
Perceptive Informatics has expanded its offering for trials involving Alzheimer's disease with a new medical imaging method, which it claims produces higher quality, reproducible and regulatory compliant assessments.
Using a modified version of nuclear magnetic resonance technology,
(NMR) scientists have revealed the therapeutic potential of an
insect's venom, which could be utilised to provide a better
understanding of Alzheimer's disease...